Tikk, K., Czock, D., Haefeli, W. E., Kopp-Schneider, A., & Brenner, H. (2018). Clinical trial protocol of the ASTER trial: A double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms. BioMed Central ; Springer. https://doi.org/10.1186/s12885-018-4826-3
Chicago-Zitierstil (17. Ausg.)Tikk, Kaja, David Czock, Walter E. Haefeli, Annette Kopp-Schneider, und Hermann Brenner. Clinical Trial Protocol of the ASTER Trial: A Double-blind, Randomized, Placebo-controlled Phase III Trial Evaluating the Use of Acetylsalicylic Acid (ASA) for Enhanced Early Detection of Colorectal Neoplasms. London Heidelberg Berlin: BioMed Central ; Springer, 2018. https://doi.org/10.1186/s12885-018-4826-3.
MLA-Zitierstil (9. Ausg.)Tikk, Kaja, et al. Clinical Trial Protocol of the ASTER Trial: A Double-blind, Randomized, Placebo-controlled Phase III Trial Evaluating the Use of Acetylsalicylic Acid (ASA) for Enhanced Early Detection of Colorectal Neoplasms. BioMed Central ; Springer, 2018. https://doi.org/10.1186/s12885-018-4826-3.